Dec 18 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Thursday it had filed a marketing application with the U.S. Food and Drug Administration for CagriSema, its once-weekly ...

Novo Nordisk (NVO) announced on Thursday it filed a U.S. marketing application for its next-gen weight loss therapy, CagriSema, which combines its blockbuster obesity drug semaglutide with an amylin ...

Retatrutide shows highest weight loss to date in trial Lilly says trial departures due to perceived excessive weight loss Retatrutide shows elevated skin-related side effects Dec 11 (Reuters) - Eli ...

(REUTERS) — Eli Lilly said on Thursday its next-generation obesity drug helped patients lose an average of 28.7% of their weight in a late-stage trial, outperforming its blockbuster drug Zepbound and ...

Eli Lilly LLY3.33%increase; green up pointing triangle said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, ...

A government-appointed committee tasked with assessing the losses incurred during the Gen-Z movement and preparing plans for the reconstruction of public infrastructure has submitted its report to ...

Lilly's Next-Gen Drug Shows Greater Weight Loss Than Zepbound in Late-Stage Trial By Christy Santhosh and Sriparna Roy Dec 11 (Reuters) - Eli Lilly said on Thursday its next-generation obesity ‌drug ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Eli Lilly’s ...

The anti-graft protests in September that forced Prime Minister KP Sharma Oli to resign caused more than $586 million in losses to Nepal's $42 billion economy, a government statement said on Friday.